switching from compounded semaglutide to wegovy vs. Switching from a Compounded GLP-1:
Description
doi: 10.1001/jamacardio.2023.5318
Retatrutide (LY3437943) is a novel synthetic peptide developed by Eli Lilly and Company
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 5, 163-172
In addition to these direct effects on the kidney and the heart, it is likely that GLP-1 regulates diuresis and natriuresis via neural mechanisms as well
Webb, V
